Success Metrics

Clinical Success Rate
93.3%

Based on 14 completed trials

Completion Rate
93%(14/15)
Active Trials
1(6%)
Results Posted
43%(6 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_1
2
12%
Ph phase_3
6
35%
Ph phase_4
2
12%
Ph phase_2
7
41%

Phase Distribution

2

Early Stage

7

Mid Stage

8

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
2(11.8%)
Phase 2Efficacy & side effects
7(41.2%)
Phase 3Large-scale testing
6(35.3%)
Phase 4Post-market surveillance
2(11.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.5%

14 of 16 finished

Non-Completion Rate

12.5%

2 ended early

Currently Active

1

trials recruiting

Total Trials

17

all time

Status Distribution
Active(1)
Completed(14)
Terminated(2)

Detailed Status

Completed14
Terminated1
Active, not recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
1
Success Rate
93.3%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (11.8%)
Phase 27 (41.2%)
Phase 36 (35.3%)
Phase 42 (11.8%)

Trials by Status

terminated16%
active_not_recruiting16%
withdrawn16%
completed1482%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT00115609Phase 3

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

Completed
NCT01651403Phase 3

Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection

Active Not Recruiting
NCT00036452Phase 2

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Completed
NCT02479880Phase 4

Utilization and Efficacy of Tenofovir DF in Adolescents With Chronic Hepatitis B Virus Infection

Terminated
NCT00528957Phase 3

Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children

Completed
NCT02039362Phase 4

Prevention of Hepatitis B Virus Vertical Transmission by Serovaccination and Tenofovir During Pregnancy

Completed
NCT00078182Phase 2

Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia

Withdrawn
NCT00507507Phase 2

A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT)

Completed
NCT00352053Phase 3

Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy

Completed
NCT01334567Phase 2

Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan

Completed
NCT00036634Phase 1

A Dose Escalation Study of Tenofovir Alafenamide in Treatment-Naive Patients

Completed
NCT00307489Phase 2

Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil

Completed
NCT00234910Phase 3

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Completed
NCT00647946Phase 2

Study to Evaluate Changes in Limb Fat When Switching From a Thymidine Analogue

Completed
NCT00024986Phase 1

Tenofovir Disoproxil Fumarate to Treat Pediatric HIV

Completed
NCT00038220Phase 2

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients

Completed
NCT00043966Phase 3

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

Completed

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17